AAAAAA

   
Results: 1-17 |
Results: 17
ADJUVANT CMFVP VERSUS ADJUVANT CMFVP PLUS OVARIECTOMY FOR PREMENOPAUSAL, NODE-POSITIVE, AND ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: RIVKIN SE GREEN S OSULLIVAN J CRUZ AB ABELOFF MD JEWELL WR COSTANZI JJ FARRAR WB OSBORNE CK
Citation: Se. Rivkin et al., ADJUVANT CMFVP VERSUS ADJUVANT CMFVP PLUS OVARIECTOMY FOR PREMENOPAUSAL, NODE-POSITIVE, AND ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 14(1), 1996, pp. 46-51
EFFICACY OF AN ELECTIVE REGIONAL LYMPH-NODE DISSECTION OF 1 TO 4 MM THICK MELANOMAS FOR PATIENTS 60 YEARS OF AGE AND YOUNGER
Authors: BALCH CM SOONG SJ BARTOLUCCI AA URIST MM KARAKOUSIS CP SMITH TJ TEMPLE WJ ROSS MI JEWELL WR MIHM MC BARNHILL RL WANEBO HJ
Citation: Cm. Balch et al., EFFICACY OF AN ELECTIVE REGIONAL LYMPH-NODE DISSECTION OF 1 TO 4 MM THICK MELANOMAS FOR PATIENTS 60 YEARS OF AGE AND YOUNGER, Annals of surgery, 224(3), 1996, pp. 255-263
SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS
Authors: ESTES NC STAUFFER J ROMBERG M THOMAS JH JEWELL WR HERMRECK A
Citation: Nc. Estes et al., SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS, The American surgeon, 62(7), 1996, pp. 573-576
TRANSHIATAL VERSUS TRANSTHORACIC ESOPHAGECTOMY FOR ADENOCARCINOMA OF THE DISTAL ESOPHAGUS AND CARDIA
Authors: STARK SP ROMBERG MS PIERCE GE HERMRECK AS JEWELL WR MORAN JF CHERIAN G DELCORE R THOMAS JH
Citation: Sp. Stark et al., TRANSHIATAL VERSUS TRANSTHORACIC ESOPHAGECTOMY FOR ADENOCARCINOMA OF THE DISTAL ESOPHAGUS AND CARDIA, The American journal of surgery, 172(5), 1996, pp. 478-482
10-YEAR RESULTS IN 1070 PATIENTS WITH STAGE-I AND STAGE-II BREAST-CANCER TREATED BY CONSERVATIVE SURGERY AND RADIATION-THERAPY
Authors: MANSFIELD CM KOMARNICKY LT SCHWARTZ GF ROSENBERG AL KRISHNAN L JEWELL WR ROSATO FE MOSES ML HAGHBIN M TAYLOR J
Citation: Cm. Mansfield et al., 10-YEAR RESULTS IN 1070 PATIENTS WITH STAGE-I AND STAGE-II BREAST-CANCER TREATED BY CONSERVATIVE SURGERY AND RADIATION-THERAPY, Cancer, 75(9), 1995, pp. 2328-2336
QUANTITATIVE ASSAY FOR THE RADIOSENSITIVITY OF MALIGNANT MELANOMAS
Authors: KRISHNAN EC KRISHNAN L SCHWEIGER GD JEWELL WR
Citation: Ec. Krishnan et al., QUANTITATIVE ASSAY FOR THE RADIOSENSITIVITY OF MALIGNANT MELANOMAS, Melanoma research, 4(3), 1994, pp. 151-155
RANDOMIZED TRIAL OF VITAMIN-A VERSUS OBSERVATION AS ADJUVANT THERAPY IN HIGH-RISK PRIMARY MALIGNANT-MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: MEYSKENS FL LIU PY TUTHILL RJ SONDAK VK FLETCHER WS JEWELL WR SAMLOWSKI W BALCERZAK SP RECTOR DJ NOYES RD COSTANZI JJ
Citation: Fl. Meyskens et al., RANDOMIZED TRIAL OF VITAMIN-A VERSUS OBSERVATION AS ADJUVANT THERAPY IN HIGH-RISK PRIMARY MALIGNANT-MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(10), 1994, pp. 2060-2065
ADJUVANT CMFVP VERSUS TAMOXIFEN VERSUS CONCURRENT CMFVP AND TAMOXIFENFOR POSTMENOPAUSAL, NODE-POSITIVE, AND ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: RIVKIN SE GREEN S METCH B CRUZ AB ABELOFF MD JEWELL WR COSTANZI JJ FARRAR WB MINTON JP OSBORNE CK
Citation: Se. Rivkin et al., ADJUVANT CMFVP VERSUS TAMOXIFEN VERSUS CONCURRENT CMFVP AND TAMOXIFENFOR POSTMENOPAUSAL, NODE-POSITIVE, AND ESTROGEN RECEPTOR-POSITIVE BREAST-CANCER PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(10), 1994, pp. 2078-2085
THE ROLE OF RADIOTHERAPY IN THE TREATMENT OF BREAST-CANCER - RESULTS OF PERIOPERATIVE IMPLANTATION
Authors: MANSFIELD CM KOMAMICKY LT REISINGER S ROSENBERG AL KRISHNAN L JEWELL WR BENAMMAR A TAYLOR J
Citation: Cm. Mansfield et al., THE ROLE OF RADIOTHERAPY IN THE TREATMENT OF BREAST-CANCER - RESULTS OF PERIOPERATIVE IMPLANTATION, Cancer detection and prevention, 18(6), 1994, pp. 493-499
PREVALENCE OF ANEUPLOIDY, OVEREXPRESSED ER, AND OVEREXPRESSED EGFR INRANDOM BREAST ASPIRATES OF WOMEN AT HIGH AND LOW-RISK FOR BREAST-CANCER
Authors: FABIAN CJ ZALLES C KAMEL S KIMLER BF MCKITTRICK R TRANIN AS ZEIGER S MOORE WP HASSANEIN RS SIMON C JOHNSON N VERGARA G JEWELL WR LIN F BHATIA P CHIN T
Citation: Cj. Fabian et al., PREVALENCE OF ANEUPLOIDY, OVEREXPRESSED ER, AND OVEREXPRESSED EGFR INRANDOM BREAST ASPIRATES OF WOMEN AT HIGH AND LOW-RISK FOR BREAST-CANCER, Breast cancer research and treatment, 30(3), 1994, pp. 263-274
PERIOPERATIVE IMPLANTATION OF IR-192 AS THE BOOST TECHNIQUE FOR STAGE-I AND STAGE-II BREAST-CANCER - RESULTS OF A 10-YEAR STUDY OF 655 PATIENTS
Authors: MANSFIELD CM KOMARNICKY LT SCHWARTZ GF ROSENBERG AL KRISHNAN L JEWELL WR ROSATO FE MOSES ML BARBOT D COHN HE GILLUM DR TAYLOR J BENAMMAR A SWENSSON L
Citation: Cm. Mansfield et al., PERIOPERATIVE IMPLANTATION OF IR-192 AS THE BOOST TECHNIQUE FOR STAGE-I AND STAGE-II BREAST-CANCER - RESULTS OF A 10-YEAR STUDY OF 655 PATIENTS, Radiology, 192(1), 1994, pp. 33-36
RECRUITMENT WITH HIGH PHYSIOLOGICAL DOSES OF ESTRADIOL PRECEDING CHEMOTHERAPY - FLOW CYTOMETRIC AND THERAPEUTIC RESULTS IN WOMEN WITH LOCALLY ADVANCED BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: FABIAN CJ KIMLER BF MCKITTRICK R PARK CH LIN F KRISHNAN L JEWELL WR OSBORNE CK MARTINO S HUTCHINS LF LEONG LA GREEN S
Citation: Cj. Fabian et al., RECRUITMENT WITH HIGH PHYSIOLOGICAL DOSES OF ESTRADIOL PRECEDING CHEMOTHERAPY - FLOW CYTOMETRIC AND THERAPEUTIC RESULTS IN WOMEN WITH LOCALLY ADVANCED BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Cancer research, 54(20), 1994, pp. 5357-5362
ONE VERSUS 2 YEARS OF CMFVP ADJUVANT CHEMOTHERAPY IN AXILLARY NODE-POSITIVE AND ESTROGEN-RECEPTOR NEGATIVE PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: RIVKIN SE GREEN S METCH B JEWELL WR COSTANZI JJ ALTMAN SJ MINTON JP OBRYAN RM OSBORNE CK
Citation: Se. Rivkin et al., ONE VERSUS 2 YEARS OF CMFVP ADJUVANT CHEMOTHERAPY IN AXILLARY NODE-POSITIVE AND ESTROGEN-RECEPTOR NEGATIVE PATIENTS - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 11(9), 1993, pp. 1710-1716
PRESERVATION OF AUGMENTED BREASTS IN PATIENTS WITH BREAST-CANCER
Authors: KRISHNAN L KRISHNAN EC WOLF CD JEWELL WR
Citation: L. Krishnan et al., PRESERVATION OF AUGMENTED BREASTS IN PATIENTS WITH BREAST-CANCER, Radiographics, 13(4), 1993, pp. 831-839
EFFICACY OF 2-CM SURGICAL MARGINS FOR INTERMEDIATE-THICKNESS MELANOMAS (1 TO 4 MM) - RESULTS OF A MULTIINSTITUTIONAL RANDOMIZED SURGICAL TRIAL
Authors: BALCH CM URIST MM KARAKOUSIS CP SMITH TJ TEMPLE WJ DRZEWIECKI K JEWELL WR BARTOLUCCI AA MIHM MC BARNHILL R WANEBO HJ
Citation: Cm. Balch et al., EFFICACY OF 2-CM SURGICAL MARGINS FOR INTERMEDIATE-THICKNESS MELANOMAS (1 TO 4 MM) - RESULTS OF A MULTIINSTITUTIONAL RANDOMIZED SURGICAL TRIAL, Annals of surgery, 218(3), 1993, pp. 262-269
BREAST BIOPSY FOR NONPALPABLE LESIONS - A WORTHWHILE ENDEAVOR
Authors: OPIE H ESTES NC JEWELL WR CHANG CHJ THOMAS JA ESTES MA PRINTEN K LLOYD LR
Citation: H. Opie et al., BREAST BIOPSY FOR NONPALPABLE LESIONS - A WORTHWHILE ENDEAVOR, The American surgeon, 59(8), 1993, pp. 490-494
PELVIC EXENTERATION - A TREATMENT FOR FAILED RECTAL-CANCER SURGERY
Authors: ESTES NC THOMAS JH JEWELL WR BEGGS D HARDIN CA",PRINTEN
Citation: Nc. Estes et al., PELVIC EXENTERATION - A TREATMENT FOR FAILED RECTAL-CANCER SURGERY, The American surgeon, 59(7), 1993, pp. 420-422
Risultati: 1-17 |